search
Back to results

High Versus Low Power Settings During Ureteroscopic Laser Lithotripsy

Primary Purpose

Renal Stone

Status
Recruiting
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Laser power settings (Thulium Fiber Laser)
Sponsored by
Haukeland University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Renal Stone

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patients ≥ 18 years scheduled for URS lithotripsy for renal stones, 8-25 mm, at the day surgery unit at Haukeland University Hospital Exclusion Criteria: Concomitant ureteral stone Urinary diversion Active infection Untreated cancer in the upper urinary tract

Sites / Locations

  • Haukeland University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Group 1 - low power laser settings

Group 2 - high power laser settings

Arm Description

4-6 Watts, short pulse mode. 0.4 - 0.6 J at 10 Hz.

16-18 Watts, short pulse mode. 0.4 J / 40 Hz, 0.6 J / 30 Hz or 0.8 J / 20 Hz.

Outcomes

Primary Outcome Measures

Operative time
Surgical time in minutes, counted from start of the procedure with insertion of the cystoscope until emptying the bladder in the end.

Secondary Outcome Measures

Stone free rate
Assessment of stone free status (or the presence of residual fragments) on low dose CT 3 months post endoscopically.
Laser activation patterns - duration
Duration of laser activation periods during laser lithotripsy in seconds
Laser activation patterns - number
Number of laser activation periods during laser lithotripsy
Intraoperative complications
Complications occurred during the endoscopic procedure (bleeding, perforation, avulsion, mucosal abrasion, blurred vision)
Post operative complications
Complications occurred after the endoscopic procedure (up to 3 months post endoscopically).

Full Information

First Posted
December 29, 2022
Last Updated
February 20, 2023
Sponsor
Haukeland University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05697250
Brief Title
High Versus Low Power Settings During Ureteroscopic Laser Lithotripsy
Official Title
High Versus Low Power Settings During Ureteroscopic Laser Lithotripsy - a Prospective, Randomised Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 23, 2023 (Actual)
Primary Completion Date
June 30, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Haukeland University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary aim of the study is to compare the operative times following ureteroscopic lithotripsy for renal stones with Thulium Fiber Laser using low and high power settings. Secondary aims are to compare the results of low and high power settings in terms of stone free rates, laser time, laser activation patterns, intraoperative and postoperative complications. Patients ≥ 18 years with renal stones (8-25 mm) scheduled for ureteroscopic lithotripsy at the Day Surgery Clinic at Haukeland University Hospital in Bergen, Norway, are eligible for inclusion in the study. After written consent and inclusion, patients are randomised to laser lithotripsy using either low power settings (Group 1: 4-6 Watt, short pulse mode) or high power settings (Group 2: 16-18 Watt, short pulse mode). The ureteroscopic procedures are performed in general anaesthesia using a standardised technique. All patients are followed up with a low dose CT scan 3 months post endoscopically to assess stone free status as well as a consultation at the outpatient clinic. Results and data for the two randomisation groups are compared according to the aims of the study.
Detailed Description
BACKGROUND: The Holmium:Yttrium-Aluminium-Garnet (Ho:YAG) has been considered the gold-standard laser for ureteroscopy (URS) because of its versatility, with the ability to break all kinds of stones in the urinary tract as well as tumor- and soft tissue ablation. Recently, a new Thulium fiber laser (TFL) has been introduced, with more favourable basic physical characteristics. Previous pre-clinical studies have predicted TFL lithotripsy to be up to four times faster than Ho:YAG lithotripsy using the same power settings. Earlier this year the present investigators published the first clinical randomised trial comparing the outcomes after ureteroscopic lithotripsy using TFL and Ho:YAG. The study demonstrated that the TFL gained superior stone free rate (SFR) compared to Ho:YAG, in addition to lower complication rate and shorter operative times. Due to the study, the investigators believe the TFL is emerging as the laser of choice. In the study very low laser settings were shown to be highly efficient using TFL during URS lithotripsy. However, no consensus exists on the preferred laser settings for the TFL during this procedure, and a variety of different settings have been suggested included high power settings as high as 45 Watts (W). To date, there are no clinical randomised trials comparing different laser settings for TFL to determine what is optimal regarding the clinical outcomes. AIMS OF THE STUDY: The primary aim of the study is to compare the operative times following URS lithotripsy for renal stones with TFL using low and high power settings. Secondary aims are to compare the results of low and high power settings in terms of SFR, laser time, laser activation patterns, intraoperative and postoperative complications. STUDY DESIGN: The study is planned as a prospective randomized trial. All patients ≥ 18 years scheduled to URS lithotripsy for renal stones, 8-25 mm, at the day surgery unit at Haukeland University Hospital (HUH) are invited to be enrolled in the study. After written informed consent, patients are randomized to URS TFL lithotripsy with either low or high power laser settings. LASER SETTINGS: The laser settings in the two study groups are standardized and need to be maintained throughout the procedure. Group 1 - low power (4-6W), short pulse: 0.4 - 0.6 Joules (J) at 10 Herz (Hz) Group 2 - high power (16-18W), short pulse: 0.4 J / 40 Hz 0.6 J / 30 Hz 0.8 J / 20 Hz Standard start-up settings in Group 1 (low power) is 0.4J / 10Hz (4W) and in Group 2 (high power) 0.4J / 40Hz (16W). THE URS PROCEDURE: The URS procedure is performed in general anaesthesia and prophylactic antibiotics prior to surgery start will be administered according to the department's guidelines, either according to urine culture or current local regime. The procedure starts with a cystoscopy followed by semirigid URS when considered appropriate. A safety guide wire and an access sheath can be used at the surgeon's discretion but is routinely omitted during URS at HUH. Balloon dilatation is performed on demand. Both semirigid and flexible ureteroscopes can be used for the endoscopy. Room-tempered, gravitational irrigation fluid at 60 cm height is used throughout the procedure. When reaching the stone, the envelope revealing the result of randomization for either high or low laser settings is opened. A 150μm laser fiber can be used for stone disintegration. The stone is disintegrated using TFL with predefined settings as described below and according to the randomization group. To make the procedures as similar as possible, the stone should be dusted/disintegrated to as small particles as possible rather than fragmented and retrieved. Only residual particles not suitable for further disintegration can be retrieved at the end of the procedure to render the patient stone free. A double J-stent can be placed after the procedure if deemed necessary, and if so, this is removed according to standard routine after 1-2 weeks in the outpatient clinic. FOLLOW-UP: Follow-up with computed tomography (CT) is performed at 3 months post endoscopically for all patients to assess stone free status and exclude a ureteral stricture in addition to a clinical consultation. ETHICAL CONSIDERATIONS AND APPROVALS: All patients eligible for inclusion in the study will receive oral and written information. Participation in the study is voluntarily, and the patient can choose to withdraw at any point during the study process. Inclusion in the study will only be done after the consent form is signed. The study is approved by The National Committees for Research Ethics in Norway (REK: 550740). In addition, application for approval by The Data Protection Authorities at Haukeland University Hospital has been sent.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Renal Stone

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The patients are randomised to ureteroscopic stone treatment with Thulium Fiber Laser with either low or high laser settings. The ureteroscopic procedures are performed in a standardised manner irrespective of the laser settings, and follow-up is similar in both groups.
Masking
Outcomes Assessor
Masking Description
Stone free status is assessed on low dose CT 3 months post endoscopically by an outcome assessor blinded to the randomisation.
Allocation
Randomized
Enrollment
150 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Group 1 - low power laser settings
Arm Type
Experimental
Arm Description
4-6 Watts, short pulse mode. 0.4 - 0.6 J at 10 Hz.
Arm Title
Group 2 - high power laser settings
Arm Type
Experimental
Arm Description
16-18 Watts, short pulse mode. 0.4 J / 40 Hz, 0.6 J / 30 Hz or 0.8 J / 20 Hz.
Intervention Type
Other
Intervention Name(s)
Laser power settings (Thulium Fiber Laser)
Intervention Description
Ureteroscopic lithotripsy using low power laser settings (0.4 - 0.6 J at 10 Hz corresponding to 2.4 - 6.0 Watts) or high power laser settings (0.4 J at 40 Hz, 0.6 J at 30 Hz or 0.8 J at 20 Hz corresponding to 16 - 18 Watts).
Primary Outcome Measure Information:
Title
Operative time
Description
Surgical time in minutes, counted from start of the procedure with insertion of the cystoscope until emptying the bladder in the end.
Time Frame
During surgery (approximately 1 hour), registered immediately after surgery
Secondary Outcome Measure Information:
Title
Stone free rate
Description
Assessment of stone free status (or the presence of residual fragments) on low dose CT 3 months post endoscopically.
Time Frame
3 months post endoscopically
Title
Laser activation patterns - duration
Description
Duration of laser activation periods during laser lithotripsy in seconds
Time Frame
During surgery (approximately 1 hour), registered immediately after surgery
Title
Laser activation patterns - number
Description
Number of laser activation periods during laser lithotripsy
Time Frame
During surgery (approximately 1 hour), registered immediately after surgery
Title
Intraoperative complications
Description
Complications occurred during the endoscopic procedure (bleeding, perforation, avulsion, mucosal abrasion, blurred vision)
Time Frame
During surgery (approximately 1 hour), registered immediately after surgery
Title
Post operative complications
Description
Complications occurred after the endoscopic procedure (up to 3 months post endoscopically).
Time Frame
After surgery until 3 months post endoscopically.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients ≥ 18 years scheduled for URS lithotripsy for renal stones, 8-25 mm, at the day surgery unit at Haukeland University Hospital Exclusion Criteria: Concomitant ureteral stone Urinary diversion Active infection Untreated cancer in the upper urinary tract
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Øyvind Ulvik, Assoc Prof
Phone
+47 90918595
Email
doc.ulvik@online.no
First Name & Middle Initial & Last Name or Official Title & Degree
Mathias S Æsøy, MD
Email
mathias.asoy@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Øyvind Ulvik, Assoc Prof
Organizational Affiliation
Haukeland University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Haukeland University Hospital
City
Bergen
State/Province
Vestland
ZIP/Postal Code
5021
Country
Norway
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Øyvind Ulvik, PhD
Phone
90918595
Ext
+47
Email
doc.ulvik@online.no

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

High Versus Low Power Settings During Ureteroscopic Laser Lithotripsy

We'll reach out to this number within 24 hrs